156 related articles for article (PubMed ID: 25096402)
1. Dihydropyrimidinase-like 3 facilitates malignant behavior of gastric cancer.
Kanda M; Nomoto S; Oya H; Shimizu D; Takami H; Hibino S; Hashimoto R; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
J Exp Clin Cancer Res; 2014 Aug; 33(1):66. PubMed ID: 25096402
[TBL] [Abstract][Full Text] [Related]
2. Dihydropyrimidinase-like 3 is a putative hepatocellular carcinoma tumor suppressor.
Oya H; Kanda M; Sugimoto H; Shimizu D; Takami H; Hibino S; Hashimoto R; Okamura Y; Yamada S; Fujii T; Nakayama G; Koike M; Nomoto S; Fujiwara M; Kodera Y
J Gastroenterol; 2015 May; 50(5):590-600. PubMed ID: 25173447
[TBL] [Abstract][Full Text] [Related]
3. The Expression of Melanoma-Associated Antigen D2 Both in Surgically Resected and Serum Samples Serves as Clinically Relevant Biomarker of Gastric Cancer Progression.
Kanda M; Nomoto S; Oya H; Takami H; Shimizu D; Hibino S; Hashimoto R; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
Ann Surg Oncol; 2016 Feb; 23 Suppl 2():S214-21. PubMed ID: 25743330
[TBL] [Abstract][Full Text] [Related]
4. Decreased expression of prenyl diphosphate synthase subunit 2 correlates with reduced survival of patients with gastric cancer.
Kanda M; Nomoto S; Oya H; Hashimoto R; Takami H; Shimizu D; Sonohara F; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Murotani K; Fujiwara M; Kodera Y
J Exp Clin Cancer Res; 2014 Oct; 33(1):88. PubMed ID: 25330808
[TBL] [Abstract][Full Text] [Related]
5. Diversity of clinical implication of B-cell translocation gene 1 expression by histopathologic and anatomic subtypes of gastric cancer.
Kanda M; Oya H; Nomoto S; Takami H; Shimizu D; Hashimoto R; Sueoka S; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
Dig Dis Sci; 2015 May; 60(5):1256-64. PubMed ID: 25487193
[TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of expression and methylation status of DENN/MADD domain-containing protein 2D in gastric cancer.
Kanda M; Shimizu D; Nomoto S; Takami H; Hibino S; Oya H; Hashimoto R; Suenaga M; Inokawa Y; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
Gastric Cancer; 2015 Apr; 18(2):288-96. PubMed ID: 24695972
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of dihydropyrimidinase-like 3 (DPYSL3) protein predicts poor prognosis in urothelial carcinoma.
Liang PI; Lai HY; Chan TC; Li WM; Hsing CH; Huang SK; Hsieh KL; Tseng WH; Chen TJ; Li WS; Chen HD; Kuo YH; Li CF
BMC Cancer; 2023 Jun; 23(1):599. PubMed ID: 37380971
[TBL] [Abstract][Full Text] [Related]
8. FBXO50 Enhances the Malignant Behavior of Gastric Cancer Cells.
Miwa T; Kanda M; Tanaka H; Tanaka C; Kobayashi D; Umeda S; Iwata N; Hayashi M; Yamada S; Fujii T; Fujiwara M; Kodera Y
Ann Surg Oncol; 2017 Nov; 24(12):3771-3779. PubMed ID: 28560594
[TBL] [Abstract][Full Text] [Related]
9. NOB1 Gene as a Potential Biomarker in Clinical Outcomes and Prognosis of Patients with Gastric Cancer.
Qi H; Wang Y
Clin Lab; 2018 Sep; 64(9):1469-1475. PubMed ID: 30274015
[TBL] [Abstract][Full Text] [Related]
10. AMIGO2 Expression as a Potential Prognostic Biomarker for Gastric Cancer.
Nakamura S; Kanda M; Shimizu D; Tanaka C; Inokawa Y; Hattori N; Hayashi M; Yamada S; Nakayama G; Omae K; Koike M; Kodera Y
Anticancer Res; 2020 Dec; 40(12):6713-6721. PubMed ID: 33288564
[TBL] [Abstract][Full Text] [Related]
11. Tissue
Sasahara M; Kanda M; Shimizu D; Tanaka C; Inokawa Y; Hattori N; Hayashi M; Nakayama G; Kodera Y
Anticancer Res; 2021 Feb; 41(2):609-617. PubMed ID: 33517265
[TBL] [Abstract][Full Text] [Related]
12. NEDD9 overexpression correlates with the progression and prognosis in gastric carcinoma.
Shi R; Wang L; Wang T; Xu J; Wang F; Xu M
Med Oncol; 2014 Mar; 31(3):852. PubMed ID: 24469954
[TBL] [Abstract][Full Text] [Related]
13. PRAME as a Potential Biomarker for Liver Metastasis of Gastric Cancer.
Baba H; Kanda M; Sawaki K; Umeda S; Miwa T; Shimizu D; Tanaka C; Kobayashi D; Fujiwara M; Kodera Y; Fujii T
Ann Surg Oncol; 2020 Jun; 27(6):2071-2080. PubMed ID: 31659640
[TBL] [Abstract][Full Text] [Related]
14. Metastatic pathway-specific transcriptome analysis identifies MFSD4 as a putative tumor suppressor and biomarker for hepatic metastasis in patients with gastric cancer.
Kanda M; Shimizu D; Tanaka H; Shibata M; Iwata N; Hayashi M; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
Oncotarget; 2016 Mar; 7(12):13667-79. PubMed ID: 26872374
[TBL] [Abstract][Full Text] [Related]
15. STRA6 Expression Serves as a Prognostic Biomarker of Gastric Cancer.
Nakamura S; Kanda M; Shimizu D; Sawaki K; Tanaka C; Hattori N; Hayashi M; Yamada S; Nakayama G; Omae K; Koike M; Kodera Y
Cancer Genomics Proteomics; 2020; 17(5):509-516. PubMed ID: 32859629
[TBL] [Abstract][Full Text] [Related]
16. HOX transcript antisense intergenic RNA represses E-cadherin expression by binding to EZH2 in gastric cancer.
Chen WM; Chen WD; Jiang XM; Jia XF; Wang HM; Zhang QJ; Shu YQ; Zhao HB
World J Gastroenterol; 2017 Sep; 23(33):6100-6110. PubMed ID: 28970725
[TBL] [Abstract][Full Text] [Related]
17. The lncRNA MACC1-AS1 promotes gastric cancer cell metabolic plasticity via AMPK/Lin28 mediated mRNA stability of MACC1.
Zhao Y; Liu Y; Lin L; Huang Q; He W; Zhang S; Dong S; Wen Z; Rao J; Liao W; Shi M
Mol Cancer; 2018 Mar; 17(1):69. PubMed ID: 29510730
[TBL] [Abstract][Full Text] [Related]
18. Low expression of SOCS-1 and SOCS-3 is a poor prognostic indicator for gastric cancer patients.
Li G; Xu J; Wang Z; Yuan Y; Li Y; Cai S; He Y
J Cancer Res Clin Oncol; 2015 Mar; 141(3):443-52. PubMed ID: 25261987
[TBL] [Abstract][Full Text] [Related]
19. Increased Expression of 58-kDa Microspherule Protein (MSP58) in Human Gastric Cancer Promotes Cell Proliferation and Correlates with Poor Patient Survival.
Cui J; Xi H; Cai A; Ma L; Bian S; Zhang K; Wei B; Chen L
Clin Lab; 2016; 62(6):993-1001. PubMed ID: 27468560
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of activated leukocute cell adhesion molecule in gastric cancer is associated with advanced stages and poor prognosis and miR-9 deregulation.
Ye M; Du YL; Nie YQ; Zhou ZW; Cao J; Li YF
Mol Med Rep; 2015 Mar; 11(3):2004-12. PubMed ID: 25395097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
